Drug profile · INN
aldesleukin
PROLEUKIN
aldesleukin (PROLEUKIN) is a interleukin-2 receptor agonist. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 29
News articles 0
Drug details — aldesleukin
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 29
- Data quality
- 0.81
Quick answer
aldesleukin (PROLEUKIN) is a interleukin-2 receptor agonist. Current US regulatory status: approved.
Key facts
INN aldesleukin
Brand PROLEUKIN
Mechanism Interleukin-2 receptor agonist
Target Interleukin-2 receptor
Formulation VIAL
Mechanism of action
Interleukin-2 receptor agonist
Primary target: Interleukin-2 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is aldesleukin?
aldesleukin (PROLEUKIN) is a interleukin-2 receptor agonist. Current US regulatory status: approved.
What is the brand name for aldesleukin?
PROLEUKIN is a marketed brand name for aldesleukin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of aldesleukin?
aldesleukin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.